Black Diamond Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $22k | 4.3k | 5.07 |
| 2023-12-31 | $11k | 4.0k | 2.81 |
| 2023-09-30 | $705 | 246 | 2.87 |
| 2023-06-30 | $43k | 8.5k | 5.05 |
| 2022-12-31 | $6.2k | 3.4k | 1.80 |
| 2022-09-30 | $9.0k | 5.4k | 1.67 |
| 2022-06-30 | $44k | 18k | 2.48 |
| 2022-03-31 | $58k | 21k | 2.79 |
| 2021-12-31 | $157k | 30k | 5.32 |
| 2021-09-30 | $143k | 17k | 8.49 |
| 2021-06-30 | $139k | 11k | 12.23 |
| 2021-03-31 | $1.0M | 43k | 24.27 |
| 2020-09-30 | $6.0k | 197 | 30.46 |
| 2020-06-30 | $196k | 4.7k | 42.11 |
| 2020-03-31 | $180k | 7.2k | 24.89 |